+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The Effect of Doxycycline Treatment on the Development of Protective Immunity in a Murine Model of Chlamydial Genital Infection



The Effect of Doxycycline Treatment on the Development of Protective Immunity in a Murine Model of Chlamydial Genital Infection



The Journal of Infectious Diseases 180(4): 1252-1258




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 068259599

Download citation: RISBibTeXText

DOI: 10.2307/30109928


Related references

The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection. Journal of Infectious Diseases 180(4): 1252-1258, 1999

Effect tetracycline treatment on the development of immunity to chlamydial genital infection in guinea pigs. Abstracts of the Annual Meeting of the American Society for Microbiology 84: ABSTRACT D9, 1984

The protective effect of antibody in immunity to murine chlamydial genital tract reinfection is independent of immunoglobulin A. Infection and Immunity 73(9): 6183-6186, 2005

Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: Serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection. Vaccine 13(11): 1023-1032, 1995

Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice. Science in China. Series C, Life Sciences 51(11): 973-980, 2008

Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele. Infection and Immunity 74(12): 6722-6729, 2006

Immunity to murine chlamydial genital infection. Infection and Immunity 70(6): 2741-2751, 2002

Protective role of serum antibody in immunity to chlamydial genital infection. Infection and Immunity 57(1): 299-301, 1989

Protective immunity to chlamydial genital infection: evidence from animal studies. Journal of Infectious Diseases 201 Suppl 2: S168-S177, 2010

Roxithromycin compared to doxycycline in the treatment of genital chlamydial infection and non-specific urethritis. International Journal of Std and Aids 4(2): 110-113, 1993

Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains. Infection and Immunity 68(1): 192-196, 1999

Subclinical Chlamydial Infection of the Female Mouse Genital Tract Generates a Potent Protective Immune Response: Implications for Development of Live Attenuated Chlamydial Vaccine Strains. Infection and Immunity 68(1): 192-196, 2000

Lack of an effect of antibiotic treatment on prolonged detection of chlamydial DNA in murine genital tract infection. Antimicrobial Agents and ChemoTherapy 51(7): 2646-2648, 2007

Sulfated polysaccharides and a synthetic sulfated polymer are potent inhibitors of Chlamydia trachomatis infectivity in vitro but lack protective efficacy in an in vivo murine model of chlamydial genital tract infection. Infection and Immunity 66(3): 1258-1260, 1998

Host Nectin-1 Promotes Chlamydial Infection in the Female Mouse Genital Tract, but Is Not Required for Infection in a Novel Male Murine Rectal Infection Model. Plos One 11(8): E0160511, 2017